false
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Catalog
Should Weight Management Be a Primary Treatment Go ...
Should Weight Management Be a Primary Treatment Go ...
Should Weight Management Be a Primary Treatment Goal for Type 2 Diabetes?
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video debate, Dr. David Nathan and Dr. Ildiko Lingvay discuss whether weight management should be a primary treatment goal for type 2 diabetes. Dr. Nathan argues against weight management as the primary goal, while Dr. Lingvay argues in favor of it. Dr. Nathan presents evidence from studies like the Diabetes Prevention Program, suggesting that weight loss can prevent the progression of type 2 diabetes. However, he believes that weight management should be a secondary goal compared to glycemic control. On the other hand, Dr. Lingvay emphasizes the benefits of weight loss in type 2 diabetes, citing studies that show reduced complications with bariatric surgery, such as retinopathy, nephropathy, and neuropathy. She advocates for a target of 15% weight loss achievable with medications like semaglutide and terzepatide. Dr. Nathan questions the level of evidence supporting weight loss as the primary goal and expresses concerns about cost and side effects of weight loss medications. The debate concludes with Dr. Lingvay asserting that weight loss is a primary target for holistic treatment, while Dr. Nathan maintains that glycemic control should remain the primary focus but weight management can be a secondary goal. Overall, the debate highlights the need for further research to understand the most effective approaches to treating type 2 diabetes.
Keywords
video debate
weight management
primary treatment goal
type 2 diabetes
Dr. David Nathan
Dr. Ildiko Lingvay
evidence
Diabetes Prevention Program
glycemic control
bariatric surgery
15% weight loss
medications
EndoCareers
|
Contact Us
|
Privacy Policy
|
Terms of Use
CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036
202.971.3636 | 888.363.6274
×